Alvotech (ALVO) Competitors $8.52 -0.21 (-2.41%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$8.60 +0.08 (+0.94%) As of 07/11/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALVO vs. QGEN, VTRS, ASND, MRNA, BBIO, BPMC, VRNA, ROIV, ELAN, and RVMDShould you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include Qiagen (QGEN), Viatris (VTRS), Ascendis Pharma A/S (ASND), Moderna (MRNA), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry. Alvotech vs. Its Competitors Qiagen Viatris Ascendis Pharma A/S Moderna BridgeBio Pharma Blueprint Medicines Verona Pharma PLC American Depositary Share Roivant Sciences Elanco Animal Health Revolution Medicines Alvotech (NASDAQ:ALVO) and QIAGEN (NYSE:QGEN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations. Do institutionals and insiders hold more shares of ALVO or QGEN? 70.0% of QIAGEN shares are owned by institutional investors. 0.5% of Alvotech shares are owned by insiders. Comparatively, 9.0% of QIAGEN shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is ALVO or QGEN more profitable? Alvotech has a net margin of 16.42% compared to QIAGEN's net margin of 4.68%. QIAGEN's return on equity of 14.61% beat Alvotech's return on equity.Company Net Margins Return on Equity Return on Assets Alvotech16.42% -36.37% 12.70% QIAGEN 4.68%14.61%8.80% Do analysts recommend ALVO or QGEN? Alvotech presently has a consensus target price of $18.00, suggesting a potential upside of 111.27%. QIAGEN has a consensus target price of $49.40, suggesting a potential upside of 2.64%. Given Alvotech's stronger consensus rating and higher possible upside, equities analysts plainly believe Alvotech is more favorable than QIAGEN.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alvotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00QIAGEN 0 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.30 Does the media refer more to ALVO or QGEN? In the previous week, Alvotech had 12 more articles in the media than QIAGEN. MarketBeat recorded 16 mentions for Alvotech and 4 mentions for QIAGEN. QIAGEN's average media sentiment score of 0.70 beat Alvotech's score of 0.67 indicating that QIAGEN is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alvotech 2 Very Positive mention(s) 4 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QIAGEN 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ALVO or QGEN? Alvotech has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, QIAGEN has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Which has preferable valuation and earnings, ALVO or QGEN? QIAGEN has higher revenue and earnings than Alvotech. Alvotech is trading at a lower price-to-earnings ratio than QIAGEN, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlvotech$491.98M5.22-$231.86M$0.3723.03QIAGEN$1.98B5.41$83.59M$0.40120.33 SummaryQIAGEN beats Alvotech on 11 of the 16 factors compared between the two stocks. Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALVO vs. The Competition Export to ExcelMetricAlvotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.63B$2.97B$5.62B$9.10BDividend YieldN/A2.39%5.24%4.00%P/E Ratio23.0320.7128.1320.27Price / Sales5.22288.38428.2998.73Price / CashN/A42.8637.4658.16Price / Book-6.227.638.045.49Net Income-$231.86M-$55.05M$3.18B$250.45M7 Day Performance-7.29%8.43%3.62%4.78%1 Month Performance-13.41%5.42%4.06%7.67%1 Year Performance-29.88%2.03%30.01%16.43% Alvotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALVOAlvotech2.7018 of 5 stars$8.52-2.4%$18.00+111.3%-28.5%$2.63B$491.98M23.031,032QGENQiagen3.6975 of 5 stars$48.07+0.6%$49.40+2.8%+20.4%$10.62B$1.98B120.525,765VTRSViatris2.9016 of 5 stars$8.93-0.9%$10.40+16.5%-18.5%$10.57B$14.74B-2.8232,000ASNDAscendis Pharma A/S3.5819 of 5 stars$172.60+0.2%$220.67+27.8%+28.9%$10.53B$393.54M-27.481,017News CoverageAnalyst ForecastMRNAModerna4.309 of 5 stars$27.59+1.6%$46.61+68.9%-72.6%$10.50B$3.24B-3.165,800Trending NewsBBIOBridgeBio Pharma4.585 of 5 stars$43.18-3.7%$58.85+36.3%+72.8%$8.52B$221.90M-12.23400Analyst UpgradeHigh Trading VolumeBPMCBlueprint Medicines1.2248 of 5 stars$128.18+0.1%$128.06-0.1%+9.8%$8.27B$508.82M-51.89640Positive NewsInsider TradeVRNAVerona Pharma PLC American Depositary Share2.3736 of 5 stars$94.58+0.8%$101.10+6.9%+394.0%$7.99B$42.28M-47.2930Trending NewsAnalyst ForecastROIVRoivant Sciences2.8383 of 5 stars$11.27-1.1%$17.50+55.3%+1.1%$7.74B$29.05M-45.08860Analyst UpgradeELANElanco Animal Health1.5099 of 5 stars$14.29flat$15.17+6.1%+9.0%$7.10B$4.44B19.319,000News CoverageRVMDRevolution Medicines4.5764 of 5 stars$36.79-0.3%$67.58+83.7%-12.3%$6.88B$11.58M-9.20250 Related Companies and Tools Related Companies QGEN Competitors VTRS Competitors ASND Competitors MRNA Competitors BBIO Competitors BPMC Competitors VRNA Competitors ROIV Competitors ELAN Competitors RVMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALVO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredDid you miss out on Trump’s “birthday gift” to Americans?While protestors were rallying against “King Trump,” one trader quietly spotted a 15% weekend move tied to his...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
